Patient Experiences of Psilocybin-Assisted Psychotherapy: An Interpretative Phenomenological Analysis

Belser, A. B., Agin-Liebes, G., Swift, T. C., Terrana, S., Devenot, N., Friedman, H. L., ... & Ross, S. | Journal of Humanistic Psychology | 28 April 2017

Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin

Schartner, M. M., Carhart-Harris, R. L., Barrett, A. B., Seth, A. K., & Muthukumaraswamy, S. D. | Scientific Reports | 19 April 2017

Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults

Brown, R. T., Nicholas, C. R., Cozzi, N. V., Gassman, M. C., Cooper, K. M., Muller, D., ... & Hutson, P. R. | Clinical Pharmacokinetics | 28 March 2017

An online survey of tobacco smoking cessation associated with naturalistic psychedelic use

Johnson, M. W., Garcia-Romeu, A., Johnson, P. S., & Griffiths, R. R. | Journal of Psychopharmacology | 18 January 2017

Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance

Dinis-Oliveira, R. J. | Drug Metabolism Reviews | 31 January 2017

The fibrinolytic system: A new target for treatment of depression with psychedelics

Idell, R. D., Florova, G., Komissarov, A. A., Shetty, S., Girard, R. B. S., & Idell, S. | Medical Hypotheses | 23 January 2017

Clinical potential of psilocybin as a treatment for mental health conditions

Daniel, J., & Haberman, M. | Mental Health Clinician | 1 January 2017

Psilocybin: promising results in double-blind trials require confirmation by real-world evidence

Breckenridge, A., & Grobbee, D. E. | Journal of psychopharmacology | 6 December 2016

Psilocybin-assisted psychotherapy for dying cancer patients – aiding the final trip

Spiegel, D. | Journal of psychopharmacology | 6 December 2016

Psilocybin for depression and anxiety associated with life-threatening illnesses

McCorvy, J. D., Olsen, R. H., & Roth, B. L. | Journal of psychopharmacology | 6 December 2016

The role of psychedelics in palliative care reconsidered: A case for psilocybin

Kelmendi, B., Corlett, P., Ranganathan, M., D'Souza, C., & Krystal, J. H. | Journal of psychopharmacology | 1 December 2016

Psilocybin and palliative end-of-life care

Shelton, R. C., & Hendricks, P. S. | Journal of Psychopharmacology | 1 December 2016

Psilocybin in end of life care: Implications for further research

Summergrad, P. | Journal of Psychopharmacology | 1 December 2016

Psilocybin: Psychotherapy or drug?

Goodwin, G. M. | Journal of Psychopharmacology | 1 December 2016

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial

Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., ... & Klinedinst, M. A. | Journal of Psychopharmacology | 1 December 2016

Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial

Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., ... & Su, Z. | Journal of Psychopharmacology | 1 December 2016

Psilocybin for anxiety and depression in cancer care? Lessons from the past and prospects for the future

Nutt, D. | Journal of Psychopharmacology | 1 December 2016

Serotonergic Hallucinogen-Induced Visual Perceptual Alterations

Kometer, M., & Vollenweider, F. X. | Current Topics in Behavioral Neurosciences | 30 November 2016

Psycho-existential distress in cancer patients: A return to “entheogens”

Blinderman, C. D. | Journal of Psychopharmacology | 30 November 2016

Back to the future: Research renewed on the clinical utility of psychedelic drugs

Lieberman, J. A., & Shalev, D. | Journal of Psychopharmacology | 30 November 2016

The successful return of psychedelics to psychiatry

Kleber, H. D. | Journal of Psychopharmacology | 30 November 2016

The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms

Barrett, F. S., Bradstreet, M. P., Leoutsakos, J. M. S., Johnson, M. W., & Griffiths, R. R. | Journal of Psychopharmacology | 17 November 2016

The serotonin 5-HT2C receptor and the non-addictive nature of classic hallucinogens

Canal, C. E., & Murnane, K. S. | Journal of Psychopharmacology | 15 November 2016

Tripping up addiction: the use of psychedelic drugs in the treatment of problematic drug and alcohol use

Morgan, C., McAndrew, A., Stevens, T., Nutt, D., & Lawn, W. | Current Opinion in Behavioral Sciences | 15 November 2016

Psychedelics as Medicines: An emerging new paradigm

Nichols, D. E., Johnson, M. W., & Nichols, C. D. | Clinical Pharmacology & Therapeutics | 4 November 2016